Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4874850
Max Phase: Preclinical
Molecular Formula: C55H79N19O12
Molecular Weight: 1198.36
Molecule Type: Unknown
Associated Items:
ID: ALA4874850
Max Phase: Preclinical
Molecular Formula: C55H79N19O12
Molecular Weight: 1198.36
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@H](NC(=O)CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)NC(=O)NCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C55H79N19O12/c56-22-6-26-66-55(86)74-54(62)65-25-5-11-40(69-50(84)42(28-32-14-18-35(76)19-15-32)72-47(81)38(9-3-23-63-52(58)59)68-44(77)20-21-45(78)79)49(83)73-43(29-33-30-67-37-8-2-1-7-36(33)37)51(85)70-39(10-4-24-64-53(60)61)48(82)71-41(46(57)80)27-31-12-16-34(75)17-13-31/h1-2,7-8,12-19,30,38-43,67,75-76H,3-6,9-11,20-29,56H2,(H2,57,80)(H,68,77)(H,69,84)(H,70,85)(H,71,82)(H,72,81)(H,73,83)(H,78,79)(H4,58,59,63)(H4,60,61,64)(H4,62,65,66,74,86)/t38-,39-,40-,41-,42-,43-/m0/s1
Standard InChI Key: YBRHKRVQGIMIIY-KHVQSSSXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1198.36 | Molecular Weight (Monoisotopic): 1197.6156 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):